Title of the study:
A study to assess the impact of Structured Teaching Program (STP) on the knowl edge regarding the
knowledge of Corona Virus Disease (COVID-19) among General Nursing Midwifery(GNM) students
of Ancillary Medical Training (AMT) School, Sheerinbagh, Srinagar, Kashmir.
Objectives of the study:
I. To assess the pre-test knowledge scores regarding the knowledge of Corona Virus Disease
(COVID-19) among the General Nursing Midwifery (GNM) students.
II. To assess the post-test knowledge scores regarding the knowledge of Corona Virus Disease
(COVID-19) among the General Nursing Midwifery (GNM) students.
III. To compare the pre-test and post-test knowledge scores regarding knowledge of the
Corona Virus Disease (COVID-19) among the General Nursing Midwifery (GNM) students.
IV. To find the association between the pre-test knowledge scores regarding the knowledge of
the Corona Virus Disease (COVID-19) among the General Nursing Midwifery (GNM) students with
selected Demographic variables (age, source of information, residence ).
HYPOTHESIS:
H1: There is significant increase in the mean post-test knowledge score as compared to mean pre-
test knowledge score regarding the knowledge of Corona Virus Disease (COVID-19) among the
General Nursing Midwifery (GNM) students at 0.05 level of significance.
H2: There is significant association between the pre-test knowledge regarding the knowledge of
Corona Virus Disease (COVID-19) among the General Nursing Midwifery (GNM) students with
selected Demographic variables (age, source of information, Residence) at 0.05 level of significance.
RESEARCH QUESTIONNAIRE
Dear respondent,
We the students of “BSc. Nursing 4th year” from “Government College of Nursing, Baghi -Dilawar
Khan Srinagar” are conducting a research. This questionnaire contains some questions regarding
Coronavirus disease (COVID-19). Please tick mark the option which according to you is the most
appropriate. Please be open and honest in your responses. Your responses will be used specifically
for research purposes only under high confidentiality.
Demographic Information
Age: -
(a) 18-20 years
(b) 20-22 years
(c) 22-24 years
(d) > 24 years
Source of information: -
Any previous information: (Yes/No)
(a) Parents/Relatives
(b) Teachers/Books
(c) Mass media
Residence:-
(a) Rural
(b) Urban
PART I:-Knowledge assessment regarding origin, definition, clinical manifestations, risk factors
diagnostic evaluation, and complications of Corona virus disease (COVID 19)
1. Corona virus disease 2019 (COVID-19) is:
(a) Non-contagious ( )
(b) Contagious ( )
(c) Both a and b ( )
(d) None of the above ( )
2. Corona virus disease (COVID-19) is caused by:
(a) NIPAH ( )
(b) SARS-CoV-1 ( )
(c) MERS ( )
(d) SARS CoV-2 ( )
3. The first outbreak of Corona virus disease (COVID-19) was initially reported from:
(a) Madrid City, Spain ( )
(b) Wuhan City, China ( )
(c) Rome, Italy ( )
(d) New York, USA ( )
4. On which date WHO declared Corona virus disease (COVID-19) as “public health emergency of
international concern”:
(a) 31 December, 2019 ( )
(b) 30 January, 2020 ( )
(c) 19 March, 2020 ( )
(d) 11 March 2020 ( )
5. On which date WHO declared Coronavirus disease (COVID-19) as global pandemic:
(a) 31 December, 2019 ( )
(b) 30 January, 2020 ( )
(c) 19 march, 2020 ( )
(d) 11 march 2020 ( )
6. Corona Virus comprises of:
(a) Single stranded RNA virus ( )
(b) Single stranded DNA virus ( )
(c) Double stranded RNA virus ( )
(d) Double stranded DNA virus ( )
7. Corona virus has______ generas:
(a) 5 ( )
(b) 3 ( )
(c) 4 ( )
(d) 2 ( )
8. The shape of Corona virus is:
(a) Spherical crown like projections ( )
(b) Leaf like projections ( )
(c) Brick like structure ( )
(d) None of the above ( )
9. The source of infection for corona virus disease (COVID-19) is:
(a) Infected person ( )
(b) Non infected person ( )
(c) Both a and b ( )
(d) None of the above ( )
10. The incubation period of corona virus disease (COVID-19) is:
(a) 4 days ( )
(b) 14 days ( )
(c) 10 days ( )
(d) None of the above ( )
11. The most commonest clinical manifestation seen among corona virus disease (COVID-19)
infected patients:
(a) Continous cough ( )
(b) Fever ( )
(c) Tiredness ( )
(d) All of the above ( )
12. All are the symptoms of Corona virus disease (COVID-19) except:
(a) Fever ( )
(b) Continous cough ( )
(c) Tiredness ( )
(d) Vomiting ( )
13. The most common associated risk factors for corona virus disease (COVID-19) are all except:
(a) Age ( )
(b) Comorbidity ( )
(c) Gender ( )
(d) 25 year old non-pregnant women ( )
14. The test recommended by ICMR (Indian Council of Medical Research) for corona virus disease
(COVID-19) is:
(a) Patch test ( )
(b) Antibody test ( )
(c) RT-PCR ( )
(d) None of the above ( )
15. The most preferred sample for laboratory diagnosis for corona virus disease (COVID-19) is:
(a) Venous blood sample ( )
(b) Throat and nasal swab ( )
(c) Midstream urine specimen ( )
(d) All of the above ( )
16. All are the radiological investigations for corona virus disease (COVID-19) except:
(a) Chest X –ray ( )
(b) CT scan ( )
(c) Lung ultrasound ( )
(d) PET (positron emission tomography) ( )
17. The new-born babies born by covid-positive mothers should be tested for Corona virus disease
(COVID-19) within:
(a) 14 days ( )
(b) 1 day ( )
(c) 2 days ( )
(d) 6 days ( )
18. The most common complication associated with corona virus disease (COVID-19) is:
(a) Fever ( )
(b) Dehydration ( )
(c) Pneumonia ( )
(d) Weakness ( )
19. The major cause of death among corona virus positive (COVID-19) patients:
(a) ARDS (Acute Respiratory Distress Syndrome) ( )
(b) Hepatic encephalopathy ( )
(c) Renal failure ( )
(d) Brain herniation ( )
20. The individual who are at lower risk of developing complications associated with corona virus
disease (COVID-19) are:
(a) Patient aged > 60 years ( )
(b) Under 5 children ( )
(c) Patient with comorbidities ( )
(d) Immunosuppressive patients ( )
PART-II:-Knowledge assessment regarding transmission, prevention and
management of the Corona virus disease COVID-19:
21. The most common means of transmission of Corona virus disease (COVID-19) are:
(a) Direct contact ( )
(b) Respiratory droplet ( )
(c) Fomites ( )
(d) All of the above ( )
22. The most common transmission chain among humans of Corona virus disease (COVID-19) is:
(a) Animal to humans ( )
(b) Eating bat soup ( )
(c) Person to person ( )
(d) From eating raw meat ( )
23. All are the common modes of transmission of corona virus disease (COVID-19) except:
(a) Contact ( )
(b) Blood borne ( )
(c) Droplets ( )
(d) Fomites ( )
24. The WHO (World Health Organisation) recommended preventive measures for Corona virus
disease (COVID-19) is:
(a) Hand washing ( )
(b) Covering nose and mouth with mask ( )
(c) Maintain social distance ( )
(d) All of the above ( )
25. The CDC (Center For Disease Control and Prevention) recommended social distancing maintained
by the individuals should be:
(a) 3 feet ( )
(b) 8 feet ( )
(c) 6 feet ( )
(d) 10 feet ( )
26. The precautionary method useful for prevention of Corona virus disease (COVID-19) includes all
except:
(a) Hand sterilisation ( )
(b) Social distancing ( )
(c) Wearing of face mask and gloves ( )
(d) Practicing cultural and traditional beliefs ( )
27. The right sequence for donning PPE (Personal Protective Equipment) while caring for COVID-
POSITIVE patients is:
I. Shoe cover II. Hood III. N-95 Mask IV. First pair of gloves
(a) I, II, III, IV ( )
(b) I, III, II, IV ( )
(c) I, IV, III, II ( )
(d) IV, III, II, I ( )
28. The right sequence for doffing PPE (Personal Protective Equipment) after caring for a COVID-
POSITIVE is:
I. Shoe cover II. Remove outer gloves III. Remove hood IV. Remove gown
(a) I, II, III, IV ( )
(b) II, III, I, IV ( )
(c) I, IV, III, II ( )
(d) IV, III, II, I ( )
29. How many pairs of gloves are used while caring for Corona virus disease (COVID-19) patient:
(a) 1 pair ( )
(b) 2 pairs ( )
(c) 3 pairs ( )
(d) As per preference of the nurse ( )
30. The first country to develop the COVID-19 vaccine is:
(a) China ( )
(b) UK ( )
(c) Russia ( )
(d) India ( )
31. All are COVID-19 vaccines except:
(a) Sputnik-V-Vaccine ( )
(b) Pfizer-vaccine ( )
(c) Junin vaccine ( )
(d) Moderna vaccine ( )
32. Route of administration of COVID-19 vaccine is:
(a) Intradermal over deltoid ( )
(b) Intradermal over flexor aspect of arm ( )
(c) Intramuscular over deltoid muscle ( )
(d) Intramuscular over vastus lateralis ( )
33. The number of vaccination doses required for protection against Corona virus disease (COVID-
19) is:
(a) Single dose ( )
(b) 2 doses ( )
(c) 3 doses ( )
(d) 4 doses ( )
34. Which ANTI-HIV drugs are used for Corona virus disease (COVID-19) treatment?
(a) Zidovudine ( )
(b) Nevirapine ( )
(c) Ritonavir/Lopinavir ( )
(d) Dolutegravir ( )
35. The most commonly drug used for the treatment of Corona virus disease(COVID-19) is:
(a) Hydroxychloroquine ( )
(b) Remdesivir ( )
(c) Both a and b ( )
(d) None of the above ( )
36. The most commonly drug used among Corona virus disease (COVID-19) patient with the
complication of coagulopathy is:
(a) Dexamethasone ( )
(b) Heparin ( )
(c) Remdesivir ( )
(d) All of the above ( )
37. The most common non-pharmacological measures adapted to decrease the severity of the
disease among mild cases of COVID-POSITIVE patients includes all except:
(a) Isolation ( )
(b) Symptomatic treatment ( )
(c) Supportive care ( )
(d) Oxygen support ( )
38. The first person in India vaccinated against Corona virus disease (COVID-19) was:
(a) Manish Kumar ( )
(b) Mahesh Kumar ( )
(c) Mahendar Kumar ( )
(d) Manoj Kumar ( )
39. Which form of the isolation is better suited for management of Corona virus disease (COVID-19)?
(a) Community isolation ( )
(b) Home isolation ( )
(c) Both a and b ( )
(d) None of the above ( )
40. The first vaccine developed by India against Corona virus disease (COVID-19) is :
(a) Covishield ( )
(b) Covaxin ( )
(c) Pfizer ( )
(d) Junin ( )
ANSWER KEY
PART -I PART -II
Q.No. Answers Q.No. Answers
1 b (contagious) 21 d (All of the above)
2 d (SARS-Cov2) 22 c (Person to person)
3 b (Wuhan city, China) 23 b (Blood borne)
4 b (30 January, 2020) 24 d (All of the above)
5 d (11 March, 2020) 25 c (6 Feet)
6 a (Single stranded 26 d (Practicing cultural &
RNA Virus) traditional beliefs)
7 c (4) 27 c (I, IV, III, II)
8 a (Spherical crown 28 a (I, II, III, IV)
like projections)
9 a (Infected person) 29 b (Two pairs)
10 b (14 days) 30 c (Russia)
11 d (All of the above) 31 c (Junin vaccine)
12 d (Vomiting) 32 c (Intramuscular deltoid muscle)
13 d (25 year old non- 33 b (2 doses)
pregnant)
14 c ( RT-PCR) 34 c (Ritonavir/Lopinavir)
15 b (Throat & nasal 35 c (Both a & b)
swab)
16 d (PET-Positron 36 b (Heparin)
Emission
Tomography)
17 a (14 days) 37 d (Oxygen support)
18 c (Pneumonia) 38 a (Manish Kumar)
19 a (ARDS-Acute 39 b (Home isolation)
Respiratory Distress
Syndrome)
20. b (Under 5 children) 40. b (Covaxin)
